Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10

Documenti analoghi

• Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).
  di: Kucharzik, T, et al.
  Pubblicazione: (1995)
• Importance of combined treatment with IL-10 and IL-4, but not IL-13, for inhibition of monocyte release of the Ca(2+)-binding protein MRP8/14.
  di: Lügering, N, et al.
  Pubblicazione: (1997)
• IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells
  di: Kucharzik, T, et al.
  Pubblicazione: (1998)
• Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10
  di: KUCHARZIK, T, et al.
  Pubblicazione: (1997)
• Anti-inflammatory cytokines (IL-4, IL-10, IL-13) in plasma during mesenteric infarction
  di: N. Nathan, et al.
  Pubblicazione: (1998-01-01)